Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection (Arkpime-T 1.125)

Advanced Antibiotic Injection for Effective Management of Serious Bacterial Infections

When bacterial infections become severe, choosing the right antibiotic is essential. Arkpime-T 1.125, containing Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection, is designed to provide broad-spectrum antibacterial coverage against susceptible bacteria. The combination offers enhanced protection by overcoming beta-lactamase-producing organisms, making it a preferred choice in hospitals and healthcare settings.

Whether you are a healthcare provider, distributor, hospital, or pharmaceutical business looking for a reliable Cefepime Tazobactam Injection Manufacturer, Arkpime-T 1.125 is manufactured with stringent quality standards to ensure safety, consistency, and therapeutic effectiveness.

Why Choose Arkpime-T 1.125?

Choosing the right antibiotic can significantly improve treatment outcomes. Arkpime-T 1.125 combines proven antibacterial agents to deliver dependable performance for a wide variety of bacterial infections.

Key Highlights

✔ Dual-Action Formula – Combines Cefepime and Tazobactam for enhanced antibacterial effectiveness.

✔ Broad-Spectrum Coverage – Active against numerous Gram-positive and Gram-negative bacteria.

✔ Helps Combat Resistant Bacteria – Tazobactam protects Cefepime from beta-lactamase enzymes.

✔ Hospital-Grade Quality – Manufactured under strict quality control and in GMP-compliant facilities.

✔ Trusted for Critical Care – Frequently used in hospitals for managing moderate to severe bacterial infections.

Therapeutic Uses of Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection

Healthcare professionals prescribe Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection for the treatment of infections where broad-spectrum antibiotic therapy is required.

Recommended For

✔ Lower Respiratory Tract Infections

✔ Complicated Urinary Tract Infections

✔ Skin & Soft Tissue Infections

✔ Intra-Abdominal Bacterial Infections

✔ Septicemia & Hospital-Acquired Infections

Because of its broad antibacterial spectrum, Cefepime Tazobactam Injection plays a significant role in treating infections caused by susceptible bacteria in hospitalized patients.

How Does Arkpime-T 1.125 Work?

The effectiveness of Arkpime-T 1.125 lies in its synergistic combination.

Cefepime damages the bacterial cell wall, causing bacteria to die, while Tazobactam neutralizes beta-lactamase enzymes that many bacteria produce to resist antibiotics. This combination extends antibacterial activity and improves treatment success against difficult-to-treat infections.

Benefits of Its Mechanism

• Eliminates infection-causing bacteria.

• Protects the antibiotic from bacterial resistance.

• Offers wider antibacterial coverage.

• Supports faster bacterial clearance.

• Enhances treatment effectiveness in severe infections.

The result is a reliable injectable antibiotic designed to support clinicians in managing complex bacterial infections effectively.

Recommended Dosage

The dosage of Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection varies according to the infection type, patient age, body weight, and kidney function. Administration should always be performed by trained healthcare professionals.

Dosage Recommendations

• Individualized according to clinical condition.

• Administer via the recommended intravenous or intramuscular route.

• Adjust dosage in renal impairment when required.

• Follow the complete treatment duration prescribed by the physician.

• Monitor patient response throughout therapy.

Important: Self-medication or discontinuing treatment early may reduce effectiveness and contribute to antibiotic resistance.

Possible Side Effects

Arkpime-T 1.125 (Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection) offers reliable antibacterial action with good patient tolerability. Like other antibiotics, it may cause certain side effects that vary from person to person.

Frequently Reported Side Effects

• Nausea

• Vomiting

• Loose stools

• Injection site discomfort

• Mild skin rash

Serious Side Effects (Require Immediate Medical Care)

• Severe allergic reactions

• Breathing difficulty

• Persistent diarrhea

• Neurological symptoms such as seizures

• Severe skin hypersensitivity reactions

Patients experiencing serious symptoms should seek immediate medical attention.

Safety Precautions

For safe and effective treatment, always use Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection under professional medical guidance.

Before Starting Treatment

✔ Inform your doctor if you have a history of antibiotic allergies.

✔ Discuss any kidney or liver disorders before treatment.

✔ Inform your healthcare provider about all medicines you are taking.

✔ Use during pregnancy or breastfeeding only if prescribed.

✔ Complete the full antibiotic course even if symptoms improve early.

Following these precautions helps maximize therapeutic benefits while minimizing potential risks.

Partner with a Reliable Cefepime Tazobactam Injection Manufacturer

At Arkpime-T 1.125, we are committed to delivering high-quality injectable antibiotics that meet international manufacturing standards. Our products are trusted by pharmaceutical distributors, hospitals, healthcare institutions, and marketing companies across India.

We proudly offer PCD Pharma Franchise, Third-Party Manufacturing, Contract Manufacturing, Private Label Manufacturing, Institutional Supply, and Bulk Order Services with complete business support, attractive pricing, and timely deliveries.

Partner with us today to expand your pharmaceutical business with premium-quality Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection.

Frequently Asked Questions

Is Arkpime-T 1.125 effective against resistant bacterial infections?

Yes. The presence of Tazobactam enhances the effectiveness of Cefepime against many beta-lactamase-producing bacteria, as determined by susceptibility and clinical judgment.

Can this injection be used at home?

No. Cefepime Hydrochloride 1000mg + Tazobactam Sodium 125mg Injection should be administered by qualified healthcare professionals in an appropriate clinical setting.

Can patients with kidney disease receive this medicine?

Yes, but dosage adjustments may be necessary. The treating physician will determine the appropriate dose based on kidney function.

Is Arkpime-T 1.125 available for PCD Pharma Franchise?

Yes. We offer profitable PCD Pharma Franchise opportunities along with marketing support and a wide product portfolio.

Do you provide Third-Party Manufacturing services?

Yes. We provide Third-Party Manufacturing, Contract Manufacturing, Private Label Manufacturing, and bulk pharmaceutical production for domestic and institutional requirements.